Drugs / Yigansan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03564132 | Jun 2018 → Aug 2020 | Tourette syndrome | China Medical University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Yigansan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03564132 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Yigansan as a Chinese medicine formula” NCT03564132 ↗ |
| Route | Oral | “2.5g of Yigansan granules by mouth, three times a day for 4 weeks” NCT03564132 ↗ |